New Rules for Clinical Trials of Patients With Acute Bacterial Skin and Skin-Structure Infections: Do Not Let the Perfect Be the Enemy of the Good

Health Care–Associated Invasive MRSA Infections, 2005-2008

(2010) Alexander J. Kallen   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Risk stratification and outcome of cellulitis admitted to hospital

(2010) M. Figtree et al.   JOURNAL OF INFECTION

Community-associated meticillin-resistant Staphylococcus aureus

(2010) Frank R DeLeo et al.   LANCET

Antimicrobial Agents for Complicated Skin and Skin‐Structure Infections: Justification of Noninferiority Margins in the Absence of Placebo‐Controlled Trials

(2009) Brad Spellberg et al.   CLINICAL INFECTIOUS DISEASES

Epidemiology of Healthcare-Associated Bloodstream Infection Caused by USA300 Strains of Methicillin-Resistant Staphylococcus aureus in 3 Affiliated Hospitals

(2009) Timothy C. Jenkins et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

The efficacy and safety of daptomycin vs. vancomycin for the treatment of cellulitis and erysipelas

(2009) P. E. Pertel et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Methicillin-Resistant Staphylococcus aureus Central Line–Associated Bloodstream Infections in US Intensive Care Units, 1997-2007

(2009) Deron C. Burton   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Heterogeneous Vancomycin‐Intermediate Susceptibility Phenotype in Bloodstream Methicillin‐ResistantStaphylococcus aureusIsolates from an International Cohort of Patients with Infective Endocarditis: Prevalence, Genotype, and Clinical Significance

(2009) In‐Gyu Bae et al.   JOURNAL OF INFECTIOUS DISEASES

International Nosocomial Infection Control Consortium report, data summary for 2002-2007, issued January 2008

(2008) Victor D. Rosenthal et al.   AMERICAN JOURNAL OF INFECTION CONTROL

Skin and Soft‐Tissue Infections Caused by Community‐Acquired Methicillin‐ResistantStaphylococcus aureus

(2008) Martin E. Stryjewski et al.   CLINICAL INFECTIOUS DISEASES

A Randomized, Double-Blind Trial Comparing Ceftobiprole Medocaril with Vancomycin plus Ceftazidime for the Treatment of Patients with Complicated Skin and Skin-Structure Infections

(2008) G. J. Noel et al.   CLINICAL INFECTIOUS DISEASES

Vancomycin-Resistant Staphylococcus aureus: A Perfect but Geographically Limited Storm?

(2008) F. C. Tenover   CLINICAL INFECTIOUS DISEASES

Telavancin Versus Vancomycin for the Treatment of Complicated Skin and Skin‐Structure Infections Caused by Gram‐Positive Organisms

(2008) Martin E. Stryjewski et al.   CLINICAL INFECTIOUS DISEASES

Use of digital photography and image analysis techniques to quantify erythema in health care workers

(2008) Jennifer Canning et al.   SKIN RESEARCH AND TECHNOLOGY

Influence of Vancomycin Minimum Inhibitory Concentration on the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia

(2007) A. Soriano et al.   CLINICAL INFECTIOUS DISEASES

Current issues in non-inferiority trials

(2007) Thomas R. Fleming   STATISTICS IN MEDICINE